AK105
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for AK105, covering 2020-03-02 to 2025-11-21. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma. [Phase 1]